Analysts issue upgrades and ratings across stocks
The alert lists ratings for ARRY, BAC, BHF, BWA, CASY, CROX, CX, FTRE, IONS, KMX, LAC, QNT, SMG, WMT and ZION, with brokerage attributions.
Find public news by keyword, exact ticker, category and date.
Open a ticker page for its news coverage. The news search below stays a text search.
10 results loaded, newest first. End of these results. The latest changes are still being indexed. Try again shortly for updated results.
The alert lists ratings for ARRY, BAC, BHF, BWA, CASY, CROX, CX, FTRE, IONS, KMX, LAC, QNT, SMG, WMT and ZION, with brokerage attributions.
Listed actions include ALL rated Equal Weight by Wells Fargo and multiple Buy, Overweight, Strong Buy and Outperform ratings from named firms.
TradeXchange reports top analyst actions: CBOE upgraded to OVERWEIGHT at MS; FSLY set to OUTPERFORM at Opp; HUM set to OUTPERFORM at Baird; ICLR moved to NEUTRAL at Baird; BAC set to OVERWEIGHT at Piper; JKHY upgraded to OVERWEIGHT at Piper; MTN set to BUY at UBS; VFC set to NEUTRAL at JPM.
Freshpet (NASDAQ: FRPT ) reported second-quarter financial results on Wednesday. The transcript from the company's second-quarter earnings call has been provided below. This transcript is brought to you APIs. For real-time access to our entire catalog, please visit for a consultation. View the webcast at Summary Freshp
Haemonetics (NYSE: HAE ) released first-quarter financial results and hosted an earnings call on Thursday. Read the complete transcript below. This transcript is brought to you APIs. For real-time access to our entire catalog, please visit for a consultation. The full earnings call is available at Summary Haemonetics C
Paychex (NASDAQ: PAYX ) reported first-quarter financial results on Wednesday. The transcript from the company's first-quarter earnings call has been provided below. This transcript is brought to you APIs. For real-time access to our entire catalog, please visit for a consultation. View the webcast at Summary Paychex I
BRP said second-quarter revenue was $2.2 billion and normalized EBITDA was $139 million, with results ahead of expectations despite a $145 million net tariff impact. The company lifted full-year revenue and normalized EPS guidance.
Toro said third-quarter net sales rose 8% and adjusted EPS was $1.33, while lifting full-year adjusted EPS guidance to $4.60 to $4.65.
Top Upgrades: BWXT: EQUAL WEIGHT @ WFC EXR: OUTPERFORM @ BMO LTC: BUY @ DB MAC: OVERWEIGHT @ Piper OKTA: NEUTRAL @ BAC P: BUY @ BAC SNPS: OUTPERFORM @ Baird SQM: BUY @ Citi SUI: NEUTRAL @ BAC WAT: OVERWEIGHT @ Piper